TripSitter Clinic Ltd (KETA) AI Stock Analysis

• Market Cap: C$432.78K
• Dividend Yield: N/A
• Average Volume (3M): 1.71K
• Price to Earnings (P/E): ―
• Beta (1Y): -12.92
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: CA
• Employees: N/A
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Healthcare Information Services
• EPS (TTM): >-0.01
• Shares Outstanding: 6,658,174
• 10 Day Avg. Volume: 150
• 30 Day Avg. Volume: 1,705
• PEG Ratio: 0.29
• Price to Book (P/B): -0.36
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -5.73
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 38 Underperform
• Price Target: C$0.06 ▲(1.67% Upside)
• Action: Downgraded Date: 02/15/26
• Date: Action: Downgraded 02/15/26

The score is driven primarily by very weak financial performance (near-zero revenue, ongoing losses, negative equity, and continued cash burn), which outweighs any near-term technical oversold signals. Valuation is also unattractive/unclear due to negative earnings and no dividend support.

Positive Factors

Reduced cash burn

Free cash flow losses have materially narrowed versus the very large outflows in FY2022–FY2024. A smaller absolute cash burn improves runway and reduces near-term refinancing urgency, increasing the odds management can execute a restructuring or revenue restart over months.

Structural industry demand

Operating in healthcare information services provides durable structural demand as providers and systems continue to prioritize digital information and analytics. That underlying industry traction supports potential revenue recovery if product-market fit or sales execution improves.

Ongoing disclosure cadence

A scheduled next earnings release indicates continued public reporting and governance. Regular disclosure gives stakeholders timely visibility into operational progress, financing plans or restructuring steps, enabling clearer oversight and accountability during a multi-month recovery.

Negative Factors

Revenue collapse

Revenue near zero eliminates operating scale and renders gross margins and unit economics non-informative. With minimal sales, fixed costs and selling efforts cannot be absorbed, making sustainable profitability dependent on a material and durable revenue reboot or significant restructuring.

Negative equity and rising debt

Deeply negative equity and rising debt are structural solvency concerns that constrain financing options and raise recapitalization risk. This weak capital base increases the likelihood of dilution or creditor-driven restructurings over the medium term, limiting strategic flexibility.

Persistent negative cash flow

Ongoing negative operating and free cash flows mean the business remains dependent on external funding to sustain operations. Even with moderated outflows, persistent cash deficits elevate financing and execution risk and can force cutbacks or dilutive raises within several months if revenues don't resume.

TripSitter Clinic Ltd Business Overview & Revenue Model

Company Description

TripSitter Clinic Ltd. operates a consultative virtual clinic and tele-health platform that connects patients to a licensed physician who can evaluate for a prescribed treatment program of low-dose oral ketamine medication in the United States. Its platform covers treatment for depression, anxiety, post-traumatic stress disorders, bipolar disorders, and obsessive-compulsive disorders. The company's treatment subscription plan includes consultation with a physician, oral ketamine prescription medication, treatment sessions with a licensed medical practitioner, and messaging with a licensed medical practitioner. It serves clients in California, Illinois, Arizona, Colorado, Michigan, Washington, Florida, New York, Ohio, and Virginia. TripSitter Clinic Ltd. is headquartered in Toronto, Canada.

How the Company Makes Money

TripSitter Clinic Ltd Financial Statement Overview

Summary

Financials are severely stressed: revenue has fallen to effectively zero in the most recent periods, losses persist, and shareholders’ equity is deeply negative—raising solvency and funding/dilution risk. Cash burn has moderated versus prior years but operating and free cash flow remain negative.

Income Statement

The income statement is very weak. Revenue has fallen to effectively zero in the most recent periods (TTM (Trailing-Twelve-Months) and FY2025), following steep declines after FY2023. Profitability is consistently negative, with ongoing operating losses and net losses across all periods shown, and margins are either negative or not meaningful due to near-zero revenue—indicating a lack of operating scale and poor earnings quality.

Balance Sheet

The balance sheet is highly stressed. Shareholders’ equity is deeply negative in recent periods (FY2023 onward), which is a major solvency red flag and suggests accumulated losses have overwhelmed the capital base. Debt has also risen meaningfully since FY2023, while total assets have collapsed from FY2023 levels to a very small base in FY2025/TTM (Trailing-Twelve-Months), reducing financial flexibility and increasing recapitalization/dilution risk.

Cash Flow

Cash flow remains negative, with operating cash flow and free cash flow consistently below zero, signaling ongoing cash burn. There is improvement versus the very large cash outflows seen in FY2022–FY2024, and recent free cash flow losses are smaller in absolute terms; however, cash generation is still not self-sustaining and the business likely depends on external financing to fund operations.

Breakdown	TTM	Apr 2024	Jan 2024	Jan 2023	Jan 2022	Jan 2021
Income Statement
Total Revenue	0.00	0.00	13.97K	488.30K	87.22K	0.00
Gross Profit	0.00	0.00	-4.70K	138.71K	-554.60K	0.00
EBITDA	-4.64K	-9.61K	-348.48K	-1.85M	-10.22M	-177.59K
Net Income	-4.64K	-9.61K	-304.86K	-1.87M	-26.11M	-179.33K
Balance Sheet
Total Assets	598.00	1.20K	2.83K	99.27K	1.46M	780.68K
Cash, Cash Equivalents and Short-Term Investments	598.00	1.20K	2.83K	54.85K	1.30M	772.39K
Total Debt	389.11K	339.62K	273.05K	133.50K	133.50K	17.88K
Total Liabilities	816.44K	748.57K	730.57K	548.82K	197.59K	93.36K
Stockholders Equity	-815.84K	-747.37K	-727.74K	-449.55K	1.26M	687.32K
Cash Flow
Free Cash Flow	-55.19K	-46.52K	-201.59K	-1.39M	-1.76M	-92.97K
Operating Cash Flow	-55.19K	-46.52K	-201.59K	-1.39M	-1.76M	-92.97K
Investing Cash Flow	0.00	0.00	0.00	0.00	2.30M	0.00
Financing Cash Flow	53.66K	54.91K	139.54K	136.43K	16.16K	865.37K

TripSitter Clinic Ltd Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
VHI	68 Neutral	C$538.10M	-185.55	1.45%	―	59.34%	-23.48%
CHS	53 Neutral	C$11.67M	-11.57	―	―	16.04%	-455.38%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
AIDR	48 Neutral	C$54.38M	-2.31	-207.53%	―	―	7.04%
UDOC	41 Neutral	C$11.66M	-3.92	―	―	―	48.94%
KETA	38 Underperform	C$432.78K	-7.33	―	―	―	―